BLACKSBURG, Va., April 8, 2013 – A study at the Virginia-Maryland Regional College of Veterinary Medicine has identified a chicken-killing virus as a promising treatment for prostate cancer in humans.
Researchers have discovered that a genetically engineered Newcastle disease virus, which harms chickens but not humans, kills prostate cancer cells of all kinds, including hormone-resistant cancer cells. The work of Dr. Elankumaran Subbiah, associate professor of virology in the Department of Biomedical Sciences and Pathobiology, along with Dr. Siba Samal, associate dean and chairman of the University of Maryland’s Department of Veterinary Medicine, and Shobana Raghunath, a graduate student in Subbiah’s laboratory, appears in the April 2013 issue of the Journal of Virology.
Read more: Virginia Tech study finds virus promising for prostate cancer treatment
Research led by RMIT University has shown that cheap, non-toxic nanoparticles can enhance radiotherapy treatments for cancer.
Researchers at the University of Oslo (UiO) have developed a completely new method for differentiating between breast cancer patients with high and low risks of dying from the illness.
Particle physicists have developed a new medical technology that combines PET and MRI in one. Benefit: Improved image quality and less radiation.
While scientists hotly debate the existence of cancer stem cells, three related new studies, all conducted on mice, provide some supporting evidence.